4.7 Article

Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1164/rccm.201910-1977OC

Keywords

idiopathic pulmonary fibrosis; airway basal cells; metalloproteinase 9; andecaliximab; type I IFNs

Funding

  1. Gilead Sciences
  2. Cedars-Sinai Medical Center
  3. NIH [R01HL123899]

Ask authors/readers for more resources

The study showed that MMP9 expression was increased in ABC-like cells from IPF lungs, and inhibition of MMP9 with Andecaliximab blocked TGF-β1-induced signaling. In a subset of nonresponder patients, the effect of MMP9 inhibition on TGF-β1 was limited, with an association found between I type IFN expression and this response.
Rationale: Aberrant lung remodeling in idiopathic pulmonary fibrosis (IPF) is characterized by elevated MMP9 (matrix metalloproteinase 9) expression, but the precise role of this matrix metalloproteinase in this disease has yet to be fully elucidated. Objectives: To evaluate antifibrotic effects of MMP9 inhibition on IPF. Methods: Quantitative genomic, proteomic, and functional analyses both in vitro and in vivo were used to determine MMP9 expression in IPF cells and the effects of MMP9 inhibition on profibrotic mechanisms. Measurements and Main Results: In the present study, we demonstrate that MMP9 expression was increased in airway basal cell (ABC)-like cells from IPF lungs compared with ABC cells from normal lungs. The inhibition of MMP9 activity with an anti-MMP9 antibody, andecaliximab, blocked TGF-beta 1 (transforming growth factor beta 1)-induced Smad2 phosphorylation. However, in a subset of cells from patients with IPF, TGF-beta 1 activation in their ABC-like cells was unaffected or enhanced by MMP9 blockade (i.e., nonresponders). Further analysis of nonresponder ABC-like cells treated with andecaliximab revealed an association with type I IFN expression, and the addition of IFN alpha to these cells modulated both MMP9 expression and TGF-beta 1 activation. Finally, the inhibition of MMP9 ameliorated pulmonary fibrosis induced by responder lung cells but not a nonresponder in a humanized immunodeficient mouse model of IPF. Conclusions: Together, these data demonstrate that MMP9 regulates the activation of ABC-like cells in IPF and that targeting this MMP might be beneficial to a subset of patients with IPF who show sufficient expression of type I IFNs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available